Abacavir/Related Articles: Difference between revisions
< Abacavir
Jump to navigation
Jump to search
imported>Daniel Mietchen m (Robot: encapsulating subpages template in noinclude tag) |
No edit summary |
||
| (One intermediate revision by one other user not shown) | |||
| Line 18: | Line 18: | ||
{{r|Pharmacogenomics}} | {{r|Pharmacogenomics}} | ||
{{Bot-created_related_article_subpage}} | |||
<!-- Remove the section above after copying links to the other sections. --> | <!-- Remove the section above after copying links to the other sections. --> | ||
==Articles related by keyphrases (Bot populated)== | |||
{{r|Protease inhibitor}} | |||
{{r|Zidovudine}} | |||
{{r|Emtricitabine}} | |||
Latest revision as of 13:53, 5 July 2024
- See also changes related to Abacavir, or pages that link to Abacavir or to this page or whose text contains "Abacavir".
Parent topics
Subtopics
Bot-suggested topics
Auto-populated based on Special:WhatLinksHere/Abacavir. Needs checking by a human.
- Antiviral drug [r]: A chemical that interfers with the replication cycle of viruses. [e]
- Drug toxicity [r]: Manifestations of the adverse effects of drugs administered therapeutically or in the course of diagnostic techniques. [e]
- Pharmacogenomics [r]: Branch of genetics which deals with the genetic variability in individual responses to drugs and drug metabolism (biotransformation). [e]
- Protease inhibitor [r]: Chemical compound that inhibits the functions of protease enzymes to control viral infections. [e]
- Zidovudine [r]: A reverse transcriptase inhibitor, antiviral drug used to treat viruses including HIV/AIDSs. [e]
- Emtricitabine [r]: A nucleoside reverse transcriptase inhibitor (NRTI) antiviral drug used to treat HIV/AIDS. [e]